Effect of Manmatha Rasa in the management of Premature Ejaculation

A controlled clinical study to evaluate the effect of manmatha rasa in the management of shukragata vata w.s.r. to premature ejaculation - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/058051

Enrollment

Registered

2023-09-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F524- Premature ejaculation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with cardinal symptoms of Shukragata vata (ksheepra munchana). 2.nability to control ejaculation long enough to satisfy the partner in 50% of the coital opportunities. 3.Patient who are fulfilling the diagnostic criteria of premature ejaculation. 4.Married patient with the history of active sexual contact with partner at least for six months. 5.Patient willing to sign and give consent.

Exclusion criteria

Exclusion criteria: 1.Known cases of psychological diseases like depression, anxiety, schizophrenia are excluded. 2.Patient with metabolic disorders like HTN, DM are excluded. 3.Diagnosed cases of prostatitis and BPH are excluded. 4.Patient denying consent.

Design outcomes

Primary

Measure	Time frame
Effect of trail drug over Shukragata vata (Premature Ejaculation) is assessed by questionnaires of fertility society of AustraliaTimepoint: 15day 30day 60 day	—

Secondary

Measure	Time frame
Safety of Trial drug and Adverse drug Reaction Aggravation of the Symptoms of Shukaragata Vata (P.E)Timepoint: 15day,30day,60,day	—

Countries

India

Contacts

Public ContactDr Sudarshan R Teradal

SDM Trusts Ayurvedic Medical College And Post Graduation Centre

vaidyasukumar@gmail.com9986125625

Outcome results